A New Generation of Coronary Vasodilators in Stress Perfusion Imaging

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1619-1620

  Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; APADENOSON; ASTELLAS; BINODENOSON; CORONARY VASODILATING AGENT; REGADENOSON; TRACER; UNCLASSIFIED DRUG;

ARTICLE; DRUG MECHANISM; HEART CATHETERIZATION; HEART PERFUSION; HEART STRESS; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SUPRAVENTRICULAR TACHYCARDIA; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 34248662689     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.06.062     Document Type: Note

References (13)

1. In: Iskandrian A.E., and Verani M.S. (Eds). Nuclear Cardiac Imaging: Principles and Applications. 3rd ed. (2003), Oxford University Press, New York 164-189
2. Iskandrian A.S., Verani M.S., and Heo J. Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1 (1994) 94-111
3. Verani M.S., Mahmarian J.J., Hixson J.B., Boyce T.M., and Staudacher R.A. Diagnosis of coronary artery disease with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 82 (1990) 80-87
4. Shryock J.C., Snowdy S., Baraldi P.G., Cacciari B., Spalluto G., Monopoli A., Ongini E., Baker S.P., and Belardinelli L. A2A-adenosine receptor reserve for coronary vasodilation. Circulation 98 (1998) 711-718
5. Biaggioni I., Killian T.J., Mosqueda-Garcia R., Robertson R.M., and Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation 83 (1991) 1668-1675
6. Belardinelli L., Shryock J.C., Snowdy S., Zhang Y., Monopoli A., Lozza G., Ongini E., Olsson R.A., and Dennis D.M. The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284 (1998) 1066-1073
7. Cerqueira M.D., Verani M.S., Schwaiger M., Heo J., and Iskandrian A.S. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23 (1994) 384-389
8. 2A receptor agonist. Circulation 102 (2000) 438-444
9. Udelson J.E., Heller G.V., Wackers F.J.T., Chai A., Hinchman D., Coleman P.S., Dilsizian V., Dicarli M., Hachamovitch R., Johnson J.R., et al. Randomized controlled dose-ranging study of the selective adenosine A2a-adenosine receptor reserve for coronary vasodilatation. Circulation 109 (2004) 457-464
10. Hendel R.C., Bateman T.M., Cerqueira M.D., Iskandrian A.E., Leppo J.A., Blackburn B., and Mahmarian J.J. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 46 (2005) 2069-2075
11. 2a receptor agonist. Am J Cardiol 99 (2007) 1507-1512
12. Zoghbi G.J., Htay T., Aqel R., Blackmon L., Heo J., and Iskandrian A.E. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol 47 (2006) 2296-2302
13. Srinivasan M., Herrero P., McGill J.B., Bennik J., Heere B., Lesniak D., Davila-Roman V.G., and Gropler R.J. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46 (2005) 42-48